Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -5650.91% is 91% below its 3-year average of -2957.90%, near the low end of its 3-year range (-5826.02%–-658.65%).
143.65% below its 12-month average of -2319.26%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -658.65%.
EBITDA MARGIN
-5650.91%
EBITDA MARGIN AVG TTM
-2319.26%
EBITDA MARGIN AVG 3Y
-2240.88%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-143.65%
CURRENT VS 3Y AVG
-152.17%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Bullfrog AI Holdings, Inc. Common Stock
Market Cap
$11.01M
EBITDA Margin
-5650.91%
TTM Avg
-2319.26%
3Y Avg
-2240.88%
5Y Avg
N/A
Market Cap
$11.21M
EBITDA Margin
28.31%
TTM Avg
28.31%
3Y Avg
28.31%
5Y Avg
-18969.31%
Market Cap
$10.75M
EBITDA Margin
-75.15%
TTM Avg
-68.19%
3Y Avg
-159.10%
5Y Avg
-185.14%
Market Cap
$10.74M
EBITDA Margin
-284.92%
TTM Avg
-261.31%
3Y Avg
-2315.78%
5Y Avg
-2461.07%
Market Cap
$11.41M
EBITDA Margin
-19.85%
TTM Avg
-31.46%
3Y Avg
-46.77%
5Y Avg
-56.23%
Market Cap
$10.27M
EBITDA Margin
-133689.80%
TTM Avg
-133689.80%
3Y Avg
-133689.80%
5Y Avg
-133689.80%
Market Cap
$11.94M
EBITDA Margin
-1.94%
TTM Avg
-1.94%
3Y Avg
-10.48%
5Y Avg
-10.95%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $11.01M | -5650.91% | -2319.26% | -2240.88% | N/A |
| BioVie Inc. (BIVI)vs › | $10.86M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | 28.31% | 28.31% | 28.31% | -18969.31% |
| Lifeward Ltd. (LFWD)vs › | $10.75M | -75.15% | -68.19% | -159.10% | -185.14% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -284.92% | -261.31% | -2315.78% | -2461.07% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -19.85% | -31.46% | -46.77% | -56.23% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -133689.80% | -133689.80% | -133689.80% | -133689.80% |
| IRIDEX Corporation (IRIX)vs › | $11.94M | -1.94% | -1.94% | -10.48% | -10.95% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | -1346.05% | -2835.20% | -1619.25% | -1619.25% |
Gross Margin
18.8%
EBITDA Margin
-5650.9%
Operating Margin
-5652.4%
Net Margin
-2006.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -658.65% |
| 2025-09-30 | -1881.30% |
| 2025-06-30 | -4417.84% |
| 2023-09-30 | -2005.71% |
| 2022-12-31 | -5826.02% |
